Delivery Order SPE2DB22D3004-SPE2DB24FPF45
Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The $3,023.08 order is for the supply of Rexulti 2 mg tablets to support DLA Troop Support Medical programs. No set-aside designation was used. AmerisourceBergen Drug Corporation is a prime contractor that provides pharmaceutical products and distribution services to U.S. government agencies, primarily the Department of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,774.15, is for the provision of the pharmaceutical product Rexulti 2 mg tablets. The contract has a performance period through March 27, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this award, which is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of 30-count tablets of the medication Rexulti 2 mg, with a potential value of $1,172.98 and a completion date of January 23, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has an extensive history of providing...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price valued at $10,748.27 and a completion date of June 6, 2025. The contract is for the supply of Rexulti 2 mg tablets, a prescription medication. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is a delivery order valued at $11,081.84 for the supply of the pharmaceutical product Rexulti 2 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has a period of performance through March 27, 2024. This delivery order is placed under a larger indefinite delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Rexulti 1 mg tablets in a quantity of 30 units, with a ceiling value of $3,390.53. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-competitive set-aside award. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- This is a firm fixed price delivery order valued at $15,348.61 awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Rexulti 3 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This delivery order awards $3,863.31 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price arrangement. The Defense Logistics Agency issued the award on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is not set-aside and represents a competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location, serving as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packaging) under a firm fixed price contract mechanism. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of pharmaceutical products and medical supplies. The contract, a firm fixed price delivery order with a ceiling value of $3,961.21, is for the provision of Rexulti 0.5 mg tablets. The award has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corporation serves as the prime contractor on this...